C57BL/6NCya-Camk2gem1flox/Cya
Common Name:
Camk2g-flox
Product ID:
S-CKO-01519
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Camk2g-flox
Strain ID
CKOCMP-12325-Camk2g-B6N-VA
Gene Name
Product ID
S-CKO-01519
Gene Alias
Camkg
Background
C57BL/6NCya
NCBI ID
Modification
Conditional knockout
Chromosome
14
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Camk2gem1flox/Cya mice (Catalog S-CKO-01519) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000071816
NCBI RefSeq
NM_178597
Target Region
Exon 6~9
Size of Effective Region
~2.3 kb
Detailed Document
Overview of Gene Research
Camk2g, encoding the gamma subunit of calcium/calmodulin-dependent protein kinase 2, is involved in multiple biological processes. It participates in signaling pathways such as the MPL-JAK2 pathway. CAMK2G is expressed throughout the brain and has been associated with neurodevelopmental disorders. Genetic models, especially knockout mouse models, are valuable for studying its functions [2,4,5].
In myelofibrosis, CAMK2G was identified as a novel therapeutic target. CAMK2G inhibition was effective against both JAK2 inhibitor-sensitive and resistant cells. In MPL W515L-induced MF model cells and mice, CAMK2G hetero knockout in primary bone marrow cells decreased colony-forming capacity, and inhibition with berbamine prolonged survival and reduced disease phenotypes [1]. In a Camk2g knockout mouse model, loss of CAMK2G affected motor function and innate behaviors like nest-building and marble burying, but had minimal impact on cognitive behavior [2]. In neuroblastoma, knockdown of CAMK2G inhibited neuronal differentiation and promoted migration [3].
In conclusion, model-based research reveals that CAMK2G plays important roles in biological processes such as hematopoiesis, neurodevelopment, and neuronal differentiation. The Camk2g knockout mouse models have contributed to understanding its roles in myelofibrosis and neurodevelopment-related behaviors, suggesting potential therapeutic implications for these disease areas [1,2].
References:
1. Miyauchi, Masashi, Sasaki, Ken, Kagoya, Yuki, Mizuno, Hideaki, Kurokawa, Mineo. . CAMK2G is identified as a novel therapeutic target for myelofibrosis. In Blood advances, 6, 1585-1597. doi:10.1182/bloodadvances.2020003303. https://pubmed.ncbi.nlm.nih.gov/34521112/
2. Rigter, Pomme M F, de Konink, Charlotte, van Woerden, Geeske M. 2023. Loss of CAMK2G affects intrinsic and motor behavior but has minimal impact on cognitive behavior. In Frontiers in neuroscience, 16, 1086994. doi:10.3389/fnins.2022.1086994. https://pubmed.ncbi.nlm.nih.gov/36685241/
3. Ma, Yujie, He, Cong, Lin, Weihong, Jia, Deshui, Li, Kai. 2024. CAMK2G Promotes Neuronal Differentiation and Inhibits Migration in Neuroblastoma. In Journal of pediatric surgery, 60, 161679. doi:10.1016/j.jpedsurg.2024.08.019. https://pubmed.ncbi.nlm.nih.gov/39266386/
4. Rigter, Pomme M F, de Konink, Charlotte, Dunn, Matthew J, Küry, Sébastien, van Woerden, Geeske M. 2024. Role of CAMK2D in neurodevelopment and associated conditions. In American journal of human genetics, 111, 364-382. doi:10.1016/j.ajhg.2023.12.016. https://pubmed.ncbi.nlm.nih.gov/38272033/
5. Proietti Onori, Martina, Koopal, Balwina, Everman, David B, Elgersma, Ype, van Woerden, Geeske M. 2018. The intellectual disability-associated CAMK2G p.Arg292Pro mutation acts as a pathogenic gain-of-function. In Human mutation, 39, 2008-2024. doi:10.1002/humu.23647. https://pubmed.ncbi.nlm.nih.gov/30184290/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen